In This Week’s Briefing:

MindMed Goes Public, Raises $24M USD

Mushrooms of all types are having their moment 

Another cannabis company pivots to psychedelics

Don’t forget about the risks

In This Week’s Briefing: MindMed Goes Public, Raises $24M USD Mushrooms of all types are having their moment Another cannabis company pivots to psychedelics Don’t forget about the risks

RoP Briefing: March 2

Report on Psychedelics is the leading source of independent data and intelligence for the emerging psychedelics industry.

Share RoP Briefing: March 2

Sign up to save your podcasts

RoP Briefing: March 2

RoP Briefing: March 2